promazine has been researched along with phentolamine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Churchill, GC; Moore, JB; Schymura, Y; Vasudevan, SR | 1 |
| Del Rio, J; Fuentes, JA | 1 |
| Nowak, R | 1 |
| Huguenard, P | 1 |
| Baum, T; Eckfeld, DK; Rowles, G; Shropshire, AT; Varner, LL | 1 |
| Branin, MJ; Luduena, FP | 1 |
8 other study(ies) available for promazine and phentolamine
| Article | Year |
|---|---|
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Shape-based reprofiling of FDA-approved drugs for the H₁ histamine receptor.
Topics: Animals; Antidepressive Agents; Brain; Calcium; Chlorprothixene; Databases, Chemical; HeLa Cells; High-Throughput Screening Assays; Histamine; Histamine H1 Antagonists; Humans; Male; Models, Molecular; Molecular Conformation; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Histamine H1; Structure-Activity Relationship; United States; United States Food and Drug Administration | 2012 |
Further studies on the antagonism of stereotyped behaviour induced by amphetamine.
Topics: Amphetamine; Animals; Atropine; Behavior, Animal; Benperidol; Chlorpromazine; Exploratory Behavior; Haloperidol; Male; Perphenazine; Phenothiazines; Phenoxybenzamine; Phentolamine; Pilocarpine; Promazine; Propranolol; Rats; Thioridazine; Tremorine; Trifluperidol | 1969 |
[Comparison of adrenolytic effect of oxidized and non-oxidized phenothiazine derivatives].
Topics: Animals; Aorta; Chlorpromazine; Ergotamine; In Vitro Techniques; Phenothiazines; Phentolamine; Promazine; Promethazine; Rabbits; Rats; Sympatholytics; Tolazoline | 1970 |
[Adrenergic receptor drugs in treatment of shock].
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Catecholamines; Citric Acid Cycle; Drug Synergism; Ergoloid Mesylates; Humans; Isoproterenol; Metaraminol; Norepinephrine; Pentoses; Phenoxybenzamine; Phentolamine; Promazine; Propranolol; Shock; Sympatholytics; Sympathomimetics | 1971 |
Observations on models used for the evaluation of antiarrhythmic drugs.
Topics: Alkaloids; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Atropine; Benzazepines; Bretylium Compounds; Chlorpheniramine; Diazepam; Disease Models, Animal; Dogs; Drug Antagonism; Guinea Pigs; Imipramine; Ketones; Lidocaine; Male; Meperidine; Mephentermine; Ouabain; Phentolamine; Phenytoin; Procainamide; Promazine; Promethazine; Propranolol; Quinidine | 1971 |
Protection of sympathetic alpha-receptors in vivo.
Topics: Animals; Epinephrine; Male; Parasympatholytics; Phenoxybenzamine; Phentolamine; Promazine; Rats; Sensory Receptor Cells; Sympathetic Nervous System; Sympatholytics; Trifluoperazine | 1967 |